Correspondence 0001193125-23-028587 from OSR Health, Inc. (OSRH)
OSR Health, Inc.
Date: Feb. 8, 2023 · CIK: 0001840425 · Accession: 0001193125-23-028587
AI Filing Summary & Sentiment
File numbers found in text: 333-264597
Letter
VIA EDGAR Division of Corporation Finance Office of Real Estate & Construction Registration Statement on Form S-1 Filed January 20, 2023, as amended File No. 333-264597
Re: Bellevue Life Sciences Acquisition Corp.
Dear Sir or Madam:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of Bellevue Life Sciences Acquisition Corp. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on February 9, 2023, or as soon thereafter as practicable.
Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that approximately 364 copies of the Preliminary Prospectus dated January 20, 2023 are expected to be distributed to prospective underwriters and dealers, institutional investors, retail investors and others.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
* * *
[Signature Page Follows]
Very truly yours,
CHARDAN CAPITAL MARKETS, LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP February 8, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Real Estate & Construction 100 F Street, N.E. Washington, D.C. 20549 Re: Bellevue Life Sciences Acquisition Corp. Registration Statement on Form S-1 Filed January 20, 2023, as amended File No. 333-264597 Dear Sir or Madam: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of Bellevue Life Sciences Acquisition Corp. that the effective date of the above-referenced Registration Statement be accelerated so as to permit it to become effective at 4:00 p.m. Washington D.C. time on February 9, 2023, or as soon thereafter as practicable. Pursuant to Rule 460 of the General Rules and Regulations under the Act, the undersigned advises that approximately 364 copies of the Preliminary Prospectus dated January 20, 2023 are expected to be distributed to prospective underwriters and dealers, institutional investors, retail investors and others. The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. * * * [Signature Page Follows] Very truly yours, CHARDAN CAPITAL MARKETS, LLC as Representative of the Underwriters By: /S/ GEORGE KAUFMAN Name: George Kaufman Title: Partner, Head of Investment Banking